Filing Details
- Accession Number:
- 0001209191-15-032090
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-04-03 11:53:40
- Reporting Period:
- 2015-04-02
- Filing Date:
- 2015-04-03
- Accepted Time:
- 2015-04-03 11:53:40
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1293971 | Bluebird Bio Inc. | BLUE | Biological Products, (No Disgnostic Substances) (2836) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1601797 | Eric Sullivan | C/O Bluebird Bio, Inc. 150 Second Street Cambridge MA 02141 | Principal Accounting Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2015-04-02 | 750 | $20.70 | 1,066 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2015-04-02 | 2,248 | $24.47 | 3,314 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2015-04-02 | 1,993 | $117.31 | 1,321 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2015-04-02 | 805 | $118.57 | 516 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2015-04-02 | 200 | $119.72 | 316 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Options (right to buy) | Disposition | 2015-04-02 | 750 | $0.00 | 3,500 | $20.70 |
| Common Stock | Stock Option (right to buy) | Disposition | 2015-04-02 | 2,248 | $0.00 | 2,248 | $24.47 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 7,750 | 2023-12-02 | No | 4 | M | Direct | |
| 5,502 | 2024-03-03 | No | 4 | M | Direct |
Footnotes
- The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 5, 2015.
- The range in prices for the transaction reported on this line was $117.00 to $117.8600. The average weighted price was $117.3102. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- The range in prices for the transaction reported on this line was $118.11 to $118.93. The average weighted price was $118.5722. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- The range in prices for the transaction reported on this line was $119.40 to $120.11. The average weighted price was $119.7241. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- This option vests over a four-year period, at a rate of twenty-five percent(25%) on November 11, 2014 and in 36 equal monthly installments thereafter.
- This option vests over a four-year period, at a rate of twenty-five percent(25%) on January 1, 2015 and in 36 equal monthly installments thereafter.
Billionaire Hedge Funds
